WPD, CNS Partner on Drug Development for Coronavirus, Other Antiviral Indications
WPD Pharmaceuticals has entered into a development agreement with CNS Pharmaceuticals for the development of several preclinical drug candidates including WP1122, which will be...
Regeneron and Sanofi Aim a Rheumatoid Arthritis Drug at Coronavirus
Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and Sanofi intend to find...
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that...
Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its...
Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina
Eli Lilly is set to invest more than $470m to build a new pharmaceutical manufacturing facility in North Carolina, US.
North Carolina Governor Roy Cooper...
Civica Rx partners with Thermo Fisher Scientific to develop and manufacture drugs with a history of drug shortages
Civica Rx announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...